Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma (Q43843458)

From Wikidata
Jump to navigation Jump to search
scientific article published in January 2002
edit
Language Label Description Also known as
English
Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma
scientific article published in January 2002

    Statements

    Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma (English)
    Sanjiv S Agarwala
    John Glaspy
    Steven J O'Day
    Malcolm Mitchell
    John Gutheil
    Eric Whitman
    Rene Gonzalez
    Evan Hersh
    Robert Belt
    Kristoffer Hellstrand
    Diana Wood
    John M Kirkwood
    Kurt R Gehlsen
    1 January 2002
    125-133

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit